J. Eary

发表

Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy.

A. Olshen, D. Mankoff, W. Eubank, 1998, AJR. American journal of roentgenology.

Spatial Heterogeneity in Sarcoma 18F-FDG Uptake as a Predictor of Patient Outcome

F. O’Sullivan, J. Eary, E. Conrad, 2008, Journal of Nuclear Medicine.

FDG-PET prediction of head and neck squamous cell cancer outcomes.

M. Leblanc, J. Eary, K. Krohn, 2004, Archives of otolaryngology--head & neck surgery.

Preliminary studies of monoclonal antibody lymphoscintigraphy in malignant melanoma.

J. Eary, W. Nelp, K. Krohn, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

FDG PET imaging for grading and prediction of outcome in chondrosarcoma patients

W. Brenner, J. Eary, E. Conrad, 2004, European Journal of Nuclear Medicine and Molecular Imaging.

Fluorodeoxyglucose positron emission tomography scanning: basic principles and imaging of adult soft-tissue sarcomas.

J. Eary, E. Conrad, S. Schuetze, 2004, The Journal of bone and joint surgery. American volume.

Imaging guidelines for children with Ewing sarcoma and osteosarcoma: A report from the Children's Oncology Group Bone Tumor Committee

J. Eary, S. Lessnick, R. Randall, 2008, Pediatric blood & cancer.

NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy of 3′-Deoxy-3′-[18F]fluorothymidine (FLT) as a Marker of Proliferation in Patients with Recurrent Gliomas: Preliminary Efficacy Studies

Janet F. Eary, Mark Muzi, Alexander M. Spence, 2009, Molecular Imaging and Biology.

Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: preliminary patient results.

F. O’Sullivan, D. Mankoff, J. Eary, 2002, Molecular imaging.

Statistical assessment of treatment response in a cancer patient based on pre- and post-therapy FDG-PET scans

F. O’Sullivan, J. Eary, J. O'Sullivan, 2018 .

Statistical assessment of treatment response in a cancer patient based on pre‐therapy and post‐therapy FDG‐PET scans

F. O’Sullivan, J. Eary, J. O'Sullivan, 2017, Statistics in medicine.

PET imaging of osteosarcoma.

Winfried Brenner, Janet F Eary, W. Brenner, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma.

D. Mankoff, J. Eary, E. Conrad, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.

Yoshimi Anzai, Paul Kinahan, Juergen Meyer, 2005, International journal of radiation oncology, biology, physics.

Contrast-enhanced photoacoustic imaging

M. O’Donnell, J. Eary, C. Jia, 2010, 2010 IEEE International Ultrasonics Symposium.

Challenges in clinical studies with multiple imaging probes.

F. O’Sullivan, J. Crowley, D. Mankoff, 2007, Nuclear medicine and biology.

Contrast enhancement in photoacoustic imaging

M. O’Donnell, J. Eary, C. Jia, 2009, 2009 IEEE International Ultrasonics Symposium.

NYESO-1/LAGE-1s and PRAME Are Targets for Antigen Specific T Cells in Chondrosarcoma following Treatment with 5-Aza-2-Deoxycitabine

Robin L. Jones, J. Eary, E. Conrad, 2012, PloS one.

Compromised in Patients with Mild Alzheimer Disease Brain Barrier , Is −-Amyloid Transporter at the Blood β Activity of P-Glycoprotein , a

F. O’Sullivan, S. Borson, S. Minoshima, 2014 .

Validation of an image derived blood time course extraction method for quantitation of dynamic PET [F-18]-Fluorothymidine (FLT) studies in brain cancer patients

F. O’Sullivan, J. Eary, M. Muzi, 2013 .

Abstract P4-01-02: The role of FLT PET early assessment of response to endocrine therapy for early stage breast cancer

D. Mankoff, H. Linden, J. Eary, 2013 .

Proliferation Imaging to Measure Early Cancer Response to Targeted Therapy

D. Mankoff, J. Eary, 2008, Clinical Cancer Research.

Kinetic analysis of 2-[11C]thymidine PET imaging studies: validation studies.

D. Mankoff, M. Graham, J. Eary, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Localization of radiolabeled antimyeloid antibodies in a human acute leukemia xenograft tumor model.

I. Bernstein, J. Eary, F. Appelbaum, 1992, Cancer research.

THE USE OF RADIOLABELED ANTI‐CD33 ANTIBODY TO AUGMENT MARROW IRRADIATION PRIOR TO MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA

I. Bernstein, J. Eary, W. Nelp, 1992, Transplantation.

Noninvasive imaging of experimental lung fibrosis.

J. Eary, N. Ambalavanan, Gang Liu, 2015, American Journal of Respiratory Cell and Molecular Biology.

Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab

P. Choyke, J. Eary, E. Jagoda, 2019, Molecular imaging.

Analysis of blood clearance and labeled metabolites for the estrogen receptor tracer [F-18]-16 alpha-fluoroestradiol (FES).

D. Mankoff, J. Eary, T. Tewson, 1997, Nuclear medicine and biology.

2-[C-11]thymidine imaging of malignant brain tumors.

M. Berger, F. O’Sullivan, A. Olshen, 1999, Cancer research.

Specific marrow localization of an 131I-labeled anti-myeloid antibody in normal dogs: effects of a "cold" antibody pretreatment dose on marrow localization.

I. Bernstein, J. Eary, B. Sandmaier, 1989, Experimental hematology.

Statistical Analysis of Tubular Structures in PET Imaging Data of Human Sarcoma

F. O’Sullivan, J. Eary, T. Richards, 2011 .

Comparison of different quantitative approaches to 18F-fluoride PET scans.

W. Brenner, D. Mankoff, J. Eary, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Impact of (18)F-FDG PET/CT imaging in therapeutic decisions for malignant solitary fibrous tumor of the pelvis.

Robin L. Jones, J. Eary, D. Lewis, 2013, Clinical nuclear medicine.

NY‐ESO‐1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma

Robin L. Jones, J. Eary, E. Conrad, 2012, Cancer.

Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood–Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease

F. O’Sullivan, D. Mankoff, S. Borson, 2014, The Journal of Nuclear Medicine.

(18)F-FDG PET in sarcoma treatment response imaging.

J. Eary, E. Conrad, D. Hawkins, 2011, American journal of nuclear medicine and molecular imaging.

18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2− Metastatic Breast Cancer

D. Mankoff, H. Linden, J. Eary, 2020, The Journal of Nuclear Medicine.

Identification of interleukin-2-induced complete response in metastatic renal cell carcinoma by FDG PET despite radiographic evidence suggesting persistent tumor.

D. Mankoff, J. Eary, W. Samlowski, 1997, AJR. American journal of roentgenology.

PET Beyond Pictures

J. Eary, E. Wolsztynski, 2020, PET/CT and PET/MR in Melanoma and Sarcoma.

Positron emission tomography of schwannomas: emphasizing its potential in preoperative planning.

J. Eary, E. Conrad, B. Rubin, 2004, AJR. American journal of roentgenology.

Risk assessment in liposarcoma patients based on FDG PET imaging

W. Brenner, J. Eary, E. Conrad, 2006, European Journal of Nuclear Medicine and Molecular Imaging.

TRANSLATIONAL REVIEW Noninvasive Imaging of Experimental Lung Fibrosis

J. Eary, N. Ambalavanan, V. Thannickal, 2015 .

PET imaging for Treatment Response in Cancer.

J. Eary, 2008, PET clinics.

An examination of the effect of registration errors on FDG-PET evaluation of chemotherapy response in sarcoma

F. O’Sullivan, J. Eary, J. O'Sullivan, 2012, 2012 IEEE Nuclear Science Symposium and Medical Imaging Conference Record (NSS/MIC).

Concurrent SPECT/PET-CT imaging as a method for tracking adoptively transferred T-cells in vivo

D. Mankoff, J. Eary, M. Disis, 2016, Journal of Immunotherapy for Cancer.

Detection of Proliferation in Gliomas by Positron Emission Tomography Imaging

D. Mankoff, J. Eary, D. Silbergeld, 2006 .

Kinetic Analysis of 2-[11C]Thymidine PET Imaging Studies of Malignant Brain Tumors: Compartmental Model Investigation and Mathematical Analysis

F. O’Sullivan, D. Mankoff, J. Eary, 2002 .

Imaging Cellular Proliferation as a Measure of Response to Therapy

D. Mankoff, J. Eary, K. Krohn, 2001, Journal of clinical pharmacology.

Imaging Cellular Proliferation as a Measure of Response to Therapy

D. Mankoff, J. Eary, K. Krohn, 2001 .

Solitary fibrous tumor: WHO classification, histopathological correlation contribution to the Radiology-Pathology Conference, FDG PET-CT imaging, and biological behaviors.

J. Eary, D. Lewis, Jinchun Yan, 2013, Clinical imaging.

FDG PET imaging guided re-evaluation of histopathologic response in a patient with high-grade sarcoma

J. Eary, E. Conrad, S. Schuetze, 2003, Skeletal Radiology.

Non-Hodgkin’s Lymphoma High Dose Therapy

J. Eary, 2012 .

Assessment of the metabolic activity of bone grafts with 18F-fluoride PET

W. Brenner, J. Eary, E. Conrad, 2004, European Journal of Nuclear Medicine and Molecular Imaging.

Radiolabeled antibody therapy of lymphoma.

I. Bernstein, J. Eary, F. Appelbaum, 1993, Cancer treatment and research.

Successful imaging of malignant melanoma with technetium-99m-labeled monoclonal antibodies.

J. Eary, R. Schroff, Clive S. Woodhouse, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A phase I / II trial of iodine-131 – tositumomab ( anti-CD 20 ) , etoposide , cyclophosphamide , and autologous stem cell transplantation for relapsed B-cell lymphomas

S. A. Bush, I. Bernstein, J. Eary, 2000 .

Hibernoma in the Thigh Mimicking Soft Tissue Sarcoma on FDG-PET

J. Eary, E. Conrad, M. Wimmer, 2015, Radiology case reports.

Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome.

I. Bernstein, J. Eary, R. Storb, 1999, Blood.

Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation.

S. A. Bush, J. Eary, F. Appelbaum, 1995, Blood.

Skeletal nonvisualization in a bone scan secondary to intravenous etidronate therapy.

D. M. Varney, J. Eary, S. Hommeyer, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Accumulation of(125)iodine labeled interleukin-2 in the pancreas of NOD mice.

J. Eary, O. Rolandsson, C. Greenbaum, 2001, Journal of autoimmunity.

Vascular response to radiation injury in the rat lung.

M. Graham, J. Eary, L. Peterson, 1992, Radiation research.

9. Radiolabeled antibody therapy of lymphoma

I. Bernstein, J. Eary, F. Appelbaum, 1993 .

Immunoreactivity assay for labeled anti-melanoma monoclonal antibodies.

J. Eary, W. Nelp, K. Krohn, 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Autoradiolysis of iodinated monoclonal antibody preparations.

J. Eary, W. Nelp, K. Krohn, 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Melanoma localization in nude mice with monoclonal Fab against p97.

S. Larson, J. Eary, W. Nelp, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial.

C. Chapman, J. Eary, R. Livingston, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

High-dose 166Ho-DOTMP in myeloablative treatment of multiple myeloma: pharmacokinetics, biodistribution, and absorbed dose estimation.

J. Eary, J. Rajendran, W. Bensinger, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Samarium-153-EDTMP biodistribution and dosimetry estimation.

J. Eary, F. Appelbaum, M. Stabin, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

DATA COLLECTION TECHNIQUES FOR PRERADIOIMMUNOTHERAPY IMAGING

J. Eary, L. Durack, 1995 .

Imaging and treatment of B-cell lymphoma.

I. Bernstein, J. Eary, W. Nelp, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Biodistribution and dosimetry following infusion of antibodies labeled with large amounts of 131I.

J. Eary, K. Krohn, D. Fisher, 1991, Cancer research.

Sentinel lymph node mapping for breast cancer: analysis in a diverse patient group.

D. Mankoff, J. Eary, B. Anderson, 1999, Radiology.

Internal Mammary Lymph Node Drainage Patterns in Patients With Breast Cancer Documented by Breast Lymphoscintigraphy

D. Mankoff, J. Eary, D. Byrd, 2001, Annals of Surgical Oncology.

Radiolabeled antibody therapy of human B cell lymphomas.

J. Eary, W. Nelp, D. Fisher, 1991, Advances in experimental medicine and biology.

Spatially coherent modeling of 3D FDG-PET data for assessment of intratumoral heterogeneity and uptake gradients

F. O’Sullivan, J. Eary, E. Wolsztynski, 2022, Journal of medical imaging.

PET imaging for planning cancer therapy.

J. Eary, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaque.

J. Eary, W. Nelp, F. Appelbaum, 1991, Blood.

A phase i/ii study of 166holmium-dotmp in combination with high dose chemotherapy and autologous stem cell transplant(Asct) For the treatment of patients with multiple myeloma(Mm)

J. Eary, D. Podoloff, R. Champlin, 2000 .

FDG PET but not RECIST agrees with histologic response of soft tissue sarcoma to neoadjuvant chemotherapy

K. Griffith, J. Eary, E. Conrad, 2005 .

Improving the tumor retention of radioiodinated antibody: aryl carbohydrate adducts.

I. Bernstein, J. Eary, W. Nelp, 1990, Cancer research.

131 I–anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in ﬁrst remission

I. Bernstein, J. Eary, F. Appelbaum, 2006 .

Radionuclide Joint Therapy

W. Brenner, J. Eary, 2007 .

131 I-Anti-CD45 Antibody Plus Busulfan/Cyclophosphamide in Matched Related Transplants for Acute Myeloid Leukemia in First Remission.

I. Bernstein, J. Eary, F. Appelbaum, 2004 .

Prognostic value of tumor heterogeneity evaluated by FDG-PET/CT imaging in lung cancer patients.

F. O’Sullivan, J. Eary, J. O'Sullivan, 2016 .

High-dose radioimmunotherapy of lymphomas.

I. Bernstein, J. Eary, F. Appelbaum, 1993, Cancer treatment and research.

Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support.

I. Bernstein, J. Eary, W. Nelp, 1993, The New England journal of medicine.

Importance of pre-treatment radiation absorbed dose estimation for radioimmunotherapy of non-Hodgkin's lymphoma.

I. Bernstein, J. Eary, K. Krohn, 1997, Nuclear medicine and biology.

High dose radioimmunotherapy in malignant lymphoma.

J. Eary, O. Press, 1996, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

89Zr for antibody labeling and positron emission tomography

J. Eary, K. Krohn, J. Link, 1986 .

Principles of Therapy with Unsealed Sources

J. Eary, 2007 .

Considerations for Imaging Re-188 and Re-186 Isotopes

J. Eary, J. Vanderheyden, L. Durack, 1990, Clinical nuclear medicine.

Molecular T argeting o f P latelet-Derived G rowth F actor B by I matinib M esylate i n a P atient W ith M etastatic Dermatofibrosarc oma P rotuberans

J. Eary, S. Mirza, E. Conrad, 2002 .

Detection of cardiac allograft rejection and myocyte necrosis by monoclonal antibody to cardiac myosin.

J. Eary, D. Reichenbach, R. Thomas, 1989, Transplantation.

In vitro and in situ magnetic resonance imaging signal features of atherosclerotic plaque-associated lipids.

C Yuan, C. Yuan, T. Hatsukami, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Radioimmunotherapy of B-cell lymphoma.

J. Eary, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Radiolabeled antibody therapy of lymphomas.

I. Bernstein, J. Eary, F. Appelbaum, 1995, Important advances in oncology.

High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis.

S. A. Bush, I. Bernstein, J. Eary, 2003, Blood.

Synthesis and radioiodination of tyramine cellobiose for labeling monoclonal antibodies.

J. Eary, K. Krohn, C. Badger, 1988, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Phase I study of 131I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome

I. Bernstein, J. Eary, R. Storb, 1999 .

Normal Values for Parotid Gland and Submandibular-Sublingual Salivary Gland Complex Uptake of 99mTechnetium Pertechnetate using SPECT in Mice with Respect to Age, Sex, and Circadian Rhythm

I. Steffen, W. Brenner, J. Eary, 2019, Nuklearmedizin.

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas

I. Bernstein, J. Eary, W. Nelp, 1995, The Lancet.

Improving the tumor retention of radioiodinated antibody

I. Bernstein, J. Eary, W. Nelp, 1990 .

TREATMENT OF B‐CELL LYMPHOMA WITH I‐131 LABELED MURINE MONOCLONAL ANTIBODIES.: P10

I. Bernstein, J. Eary, W. Nelp, 1987 .

A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas.

S. A. Bush, I. Bernstein, J. Eary, 2000, Blood.

Is there a better way to deliver total body irradiation?

I. Bernstein, H. Deeg, J. Eary, 1992, Bone marrow transplantation.

Predictors of 18F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy

K. Pienta, P. Choyke, J. Eary, 2021, The Journal of Nuclear Medicine.

Normal Values of Thyroid Uptake of 99mTechnetium Pertechnetate SPECT in Mice with Respect to Age, Sex, and Circadian Rhythm

I. Steffen, W. Brenner, J. Eary, 2018, Nuklearmedizin.

166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy.

J. Eary, R. Wendt, W. Erwin, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans.

J. Eary, S. Mirza, E. Conrad, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radionuclide, magnetic resonance and computed tomography imaging in European round back slugs (Arionidae) and leopard slugs (Limacidae)

W. Brenner, J. Eary, D. Messroghli, 2021, Scientific Reports.

Staging of head and neck squamous cell cancer with extended-field FDG-PET.

J. Eary, Y. Anzai, K. Krohn, 2003, Archives of otolaryngology--head & neck surgery.

NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy of FLT as a Marker of Proliferation in Patients with Recurrent Gliomas: Safety Studies

J. Hoffman, J. Eary, M. Muzi, 2008, Molecular Imaging and Biology.

Kinetic analysis of 2-[carbon-11]thymidine PET imaging studies: compartmental model and mathematical analysis.

D. Mankoff, M. Graham, J. Eary, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors.

J. Eary, E. Conrad, S. Schuetze, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Indium-111 white blood cell scan for infectious complications of polycystic renal disease.

M. Cerqueira, J. Eary, W. Nelp, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer.

D. Mankoff, W. Eubank, J. Eary, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Myeloablative radiolabeled antibody therapy with autologous bone marrow transplantation for relapsed B cell lymphomas.

I. Bernstein, J. Eary, F. Appelbaum, 1995, Cancer treatment and research.

Quantification of Functional Heterogeneities in Tumors by PET Imaging

Winfried Brenner, Florian Wedel, Janet F. Eary, 2018 .

Radioimmunotherapy strategies for non-Hodgkin's lymphomas.

I. Bernstein, J. Eary, O. Press, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Sport Concussion Assessment Tool – 2: Baseline Values for High School Athletes

Janet F Eary, J. Eary, K. Harmon, 2012, British Journal of Sports Medicine.

Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody.

J. Eary, W. Nelp, K. Krohn, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Physical activity assessment in adolescents with limb salvage.

J. Eary, E. Conrad, K. Bjornson, 2012, The Journal of pediatrics.

Nuclear medicine in cancer diagnosis

Janet F Eary, J. Eary, 1999, The Lancet.

[18F]FMISO and [18F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression

J. Eary, E. Conrad, K. Krohn, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

The tuberous sclerosis complex regulates trafficking of glucose transporters and glucose uptake.

L. Aicher, J. Eary, J. Bissler, 2008, The American journal of pathology.

High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma.

J. Eary, D. Maloney, F. Appelbaum, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8+ T cells

Robin L. Jones, J. Eary, S. Heimfeld, 2014, Journal of Immunotherapy for Cancer.

Molecular (functional) imaging for radiotherapy applications: an RTOG symposium.

Jeffrey D Bradley, Janet F Eary, S M Larson, 2003, International journal of radiation oncology, biology, physics.

Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis.

J. Eary, D. Gibson, J. Tait, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Production of [F-18]fluoroannexin for imaging apoptosis with PET.

Janet F Eary, Kenneth A Krohn, J. Eary, 2004, Bioconjugate chemistry.

High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumes.

J. Eary, J. Rajendran, D. Fisher, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

(F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma.

A. Folpe, J. Eary, E. Conrad, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Use of serial 18F-Fluorothymidine (FLT) PET and Ki-67 to predict response to aromatase inhibitors (AI) in women with ER+ breast cancer.

D. Mankoff, H. Linden, J. Eary, 2016 .

Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond

Mark Muzi, David A Mankoff, Janet F Eary, 2007, Clinical Cancer Research.

High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma.

S. A. Bush, I. Bernstein, J. Eary, 2002, Blood.

Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis

F. O’Sullivan, J. Eary, E. Conrad, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

I-Anti-CD 45 Antibody Plus Cyclophosphamide and Total Body Irradiation for Advanced Acute Leukemia and Myelodysplastic Syndrome

I. Bernstein, J. Eary, R. Storb, 1999 .

Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma.

D. Mankoff, J. Eary, R. Livingston, 2000, Cancer.

Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma

D. Mankoff, J. Eary, R. Livingston, 2000 .

Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: A case study and survey of somatostatin receptor subtype expression

D. Mankoff, J. Eary, D. Silbergeld, 2006, Head & neck.

Technical aspects of sentinel node lymphoscintigraphy for breast cancer.

D. Mankoff, J. Eary, B. Anderson, 1999, Journal of nuclear medicine technology.

131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission.

I. Bernstein, J. Eary, F. Appelbaum, 2006, Blood.

Evaluation of chemotherapy response in pediatric bone sarcomas by [F‐18]‐fluorodeoxy‐D‐glucose positron emission tomography

J. Eary, E. Conrad, D. Hawkins, 2002, Cancer.

Diagnostic Applications of Nuclear Medicine: Sarcomas

J. Eary, 2016 .

Imaging in Sarcoma

J. Eary, E. Conrad, 2011, The Journal of Nuclear Medicine.

Tumor metabolic rates in sarcoma using FDG PET.

D. Mankoff, J. Eary, J F Eary, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

2-[(18)F]Fluoro-2-deoxyglucose and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcome.

F. O’Sullivan, D. Mankoff, M. Graham, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

High Dose Radiolabeled Antibody Therapy of Lymphoma 1

I. Bernstein, J. Eary, W. Nelp, 2006 .

C11-Acetate and F-18 FDG PET for Men With Prostate Cancer Bone Metastases: Relative Findings and Response to Therapy

D. Mankoff, J. Eary, C. Higano, 2011, Clinical nuclear medicine.

Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: compartmental model investigation and mathematical analysis.

F. O’Sullivan, D. Mankoff, J. Eary, 2002, Molecular imaging.

Carbon-11-thymidine and FDG to measure therapy response.

T K Lewellen, D. Mankoff, M. Graham, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue.

S. A. Bush, I. Bernstein, J. Eary, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The use of radiolabeled antibodies in bone marrow transplantation for hematologic malignancies.

I. Bernstein, J. Eary, F. Appelbaum, 1997, Cancer treatment and research.

166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials.

J. Eary, R. Wendt, D. Maloney, 2003, Blood.

Effects of propylthiouracil on the biodistribution of an iodine-131-labeled anti-myeloid antibody in normal dogs: dosimetry and clinical implications.

I. Bernstein, J. Eary, B. Sandmaier, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[F‐18]‐fluorodeoxy‐D‐glucose–positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults

J. Eary, E. Conrad, S. Schuetze, 2009, Cancer.

A comparison of prostate cancer bone metastases on 18F-Sodium Fluoride and Prostate Specific Membrane Antigen (18F-PSMA) PET/CT: Discordant uptake in the same lesion

P. Choyke, J. Eary, M. Pomper, 2018, Oncotarget.

High-dose radioimmunotherapy of B cell lymphomas.

J. Eary, W. Nelp, K. Krohn, 1990, Frontiers of radiation therapy and oncology.

Risk Assessment Based on FDG-PET Imaging in Patients with Synovial Sarcoma

J. Eary, E. Conrad, J. O'Sullivan, 2009, Clinical orthopaedics and related research.

Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy

J. Eary, E. Conrad, S. Schuetze, 2005, Cancer.

FDG‐PET/CT–guided intensity modulated head and neck radiotherapy: A pilot investigation

Yoshimi Anzai, Paul Kinahan, Eric C Ford, 2005, Head & neck.

Radioimmunotherapy and Autologous Hematopoietic Stem-Cell Transplantation for Adults 60 Years Old With Relapsed or Refractory B-Cell Lymphoma

J. Eary, D. Maloney, F. Appelbaum, 2007 .

A Phase 2 Study of 16α-[18F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC)

D. Mankoff, H. Linden, J. Eary, 2014, Molecular Imaging and Biology.

Positron emission tomography-based assessment of metabolic gradient and other prognostic features in sarcoma

Eric Wolsztynski, Finbarr O'Sullivan, Janet F Eary, 2018, Journal of medical imaging.

Analysis of spatial patterns in tumor imaging data: A method for assessment of tubularity

F. O’Sullivan, J. Eary, J. O'Sullivan, 2014, 2014 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC).

Sarcoma mid-therapy [F-18]fluorodeoxyglucose positron emission tomography (FDG PET) and patient outcome.

F. O’Sullivan, J. Eary, E. Conrad, 2014, The Journal of bone and joint surgery. American volume.

A Statistical Modeling Approach to the Analysis of Spatial Patterns of FDG-PET Uptake in Human Sarcoma

Finbarr O'Sullivan, Eric Wolsztynski, J. F. Eary, 2011, IEEE Transactions on Medical Imaging.

Fluorodeoxyglucose positron emission tomography in leiomyosarcoma: imaging characteristics

J. Eary, E. Conrad, J. O'Sullivan, 2009, Nuclear medicine communications.

(F-18)-Fluorodeoxy-D-Glucose-

J. Eary, E. Conrad, S. Schuetze, 2009 .

Incorporation of tumor shape into an assessment of spatial heterogeneity for human sarcomas imaged with FDG-PET.

F O'Sullivan, S Roy, J O'Sullivan, 2005, Biostatistics.

A statistical measure of tissue heterogeneity with application to 3D PET sarcoma data.

Finbarr O'Sullivan, Supratik Roy, Janet Eary, 2003, Biostatistics.

Positron emission tomography: imaging tumor response

Janet F. Eary, Kenneth A. Krohn, J. Eary, 2000, European Journal of Nuclear Medicine.

Positron Emission Tomography in Grading Soft Tissue Sarcomas.

J. Eary, E. Conrad, 1999, Seminars in musculoskeletal radiology.

Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-5-Fluoro-2′-Deoxycytidine with Tetrahydrouridine in Solid Tumors

P. Choyke, J. Eary, K. Kurdziel, 2018, Journal of Nuclear Medicine.

Energy-based scatter corrections for scintillation camera images of iodine-131.

R S Miyaoka, K. R. Pollard, M. S. Kaplan, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

PET imaging: update on sarcomas.

J. Eary, E. Conrad, 2007, Oncology.

Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET.

D. Mankoff, W. Eubank, J. Eary, 2002, Radiographics : a review publication of the Radiological Society of North America, Inc.

Preliminary validation of the opposing view method for quantitative gamma camera imaging.

J. Eary, J F Eary, F L Appelbaum, 1989, Medical physics.

S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors.

J. Eary, M. Heinrich, C. Corless, 2015, The oncologist.

Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.

I. Bernstein, I. Bernstein, J. Eary, 1996, Cancer research.

Radioimaging of Melanoma with 99Tcm-labeled Monoclonal Antibodies

J. Eary, W. Nelp, S. L. Johnson, 1990 .

Tumor heterogeneity measurement using [18F] FDG PET/CT shows prognostic value in patients with non-small cell lung cancer

F. O’Sullivan, J. Eary, J. O'Sullivan, 2018, European Journal of Hybrid Imaging.

Differential-absorption photoacoustic imaging.

M. O’Donnell, J. Eary, C. Jia, 2009, Optics letters.

VOXEL-LEVEL MAPPING OF TRACER KINETICS IN PET STUDIES: A STATISTICAL APPROACH EMPHASIZING TISSUE LIFE TABLES.

Mark Muzi, Finbarr O'Sullivan, David A Mankoff, 2014, The annals of applied statistics.

18F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy

P. Choyke, M. Merino, J. Eary, 2019, The Journal of Nuclear Medicine.

High dose radiolabeled antibody therapy of lymphoma.

I. Bernstein, J. Eary, W. Nelp, 1990, Cancer Research.

Post therapy imaging in high dose I-131 radioimmunotherapy patients.

K. R. Pollard, I. Bernstein, J. Eary, 1994, Medical physics.

A method for imaging therapeutic doses of iodine-131 with a clinical gamma camera.

K. R. Pollard, T K Lewellen, J. Eary, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Localized beta dosimetry of 131I-labeled antibodies in follicular lymphoma.

I. Bernstein, J. Weinstein, J. Eary, 1992, Medical physics.

High-Dose Radioimmunotherapy of B Cell Lymphomas1

I. Bernstein, J. Eary, W. Nelp, 1989 .

A novel approach to the assessment of response to chemotherapy in sarcoma imaged with PET-FDG

F. O’Sullivan, J. Eary, E. Conrad, 2010, IEEE Nuclear Science Symposuim & Medical Imaging Conference.

Modulation of P-glycoprotein at the Human Blood-Brain Barrier by Quinidine or Rifampin Treatment: A Positron Emission Tomography Imaging Study

David A Mankoff, Janet F Eary, Jashvant D Unadkat, 2015, Drug Metabolism and Disposition.

Proton MR Spectroscopy Measurements of White and Brown Adipose Tissue in Healthy Humans: Relaxation Parameters and Unsaturated Fatty Acids.

Khaled Z. Abd-Elmoniem, J. Eary, Kong Y. Chen, 2021, Radiology.

Modulation of P-glycoprotein at the Human Blood-Brain Barrier by Quinidine or Rifampin Treatment : a PET Imaging Study

D. Mankoff, J. Eary, K. Domino, 2015 .

455 Role of Hypoxia Imaging with [F-18]FMISO-PET and BOLD-MRI in Clinical Trials

J. Eary, T. Richards, M. Muzi, 2012 .

456 FES PET is an Imaging Biomarker of Pharmacodynamic Response to Estrogen Receptor (ER) Modulating Therapies in Breast Cancer

D. Mankoff, H. Linden, J. Eary, 2012 .

Integration of photoacoustic, ultrasound, and magnetomotive system

M. O’Donnell, J. Eary, C. Jia, 2010, BiOS.

Comparison of radiation dose estimation for myeloablative radioimmunotherapy for relapsed or recurrent mantle cell lymphoma using (131)I tositumomab to that of other types of non-Hodgkin's lymphoma.

J. Eary, J. Rajendran, D. Fisher, 2004, Cancer biotherapy & radiopharmaceuticals.

Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of 18F-DCFPyL PET/CT with Comparison to Multiparametric MRI.

Baris Turkbey, Esther Mena, Joanna H Shih, 2020, Radiology.

Assessment of iodine 131 scattering and septal penetration in clinical gamma camera high energy parallel hole collimators

Janet F. Eary, K. R. Pollard, J. Eary, 1991 .

Fundamentals of radioimmunotherapy.

J. Eary, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Multiagent PET for Risk Characterization in Sarcoma

Jedediah K. White, D. Mankoff, J. Eary, 2011, The Journal of Nuclear Medicine.

CLINICAL INVESTIGATION Head and Neck FDG-PET/CT IMAGING FOR PRERADIOTHERAPY STAGING OF HEAD-AND-NECK SQUAMOUS CELL CARCINOMA

Paul Kinahan, M. Leblanc, J. Eary, 2005 .

Abstract SY42-02: Novel PET imaging in the clinic: Selecting patient cohorts and measuring early response

F. O’Sullivan, D. Mankoff, H. Linden, 2012 .

131I therapy using rhTSH stimulation and dosimetry in metastatic malignant struma ovarii.

D. Mankoff, J. Eary, D. Lewis, 2014, Clinical nuclear medicine.

Nuclear medicine in the next decade

A. Todd-Pokropek, J. Eary, O. Schober, 2000, European Journal of Nuclear Medicine.

Structural analysis of solid tumors based on regularized tubular modeling

E. Wolsztynski, J. O'Sullivan, M. P. Kennedy, 2015, 2015 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC).

C11-Acetate and F-18 FDG PET for Men With Prostate Cancer Bone Metastases: Relative Findings and Response to Therapy

D. Mankoff, J. Eary, C. Higano, 2011, Clinical nuclear medicine.

Imaging guidelines for children with Ewing sarcoma and osteosarcoma: A report from the Children's Oncology Group Bone Tumor Committee

J. Eary, S. Lessnick, R. Randall, 2008, Pediatric blood & cancer.

[F‐18]‐fluorodeoxy‐D‐glucose–positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults

J. Eary, E. Conrad, S. Schuetze, 2009, Cancer.

Antibody in Normal Dogs : Dosimetry and Clinical Implications Effects of Propylthiouracil on the Biodistribution of an Iodine-131-Labeled Anti-Myeloid

Darrell, I. Bernstein, J. Eary, 2006 .

Effects of Propyithiouracil on the Biodistribution of an Iodine-13 1-Labeled Anti-Myeloid Antibody in Normal Dogs : Dosimetry and Clinical Implications

I. Bernstein, J. Eary, B. Sandmaier, 2006 .

Response to “imaging guidelines for children with Ewing sarcoma and osteosarcoma: A report from the Children's Oncology Group Bone Tumor Committee”

J. Eary, S. Lessnick, R. Randall, 2008 .

Vorinostat to restore sensitivity to aromatase inhibitor therapy in metastatic breast cancer: A phase II clinical trial with ER imaging correlates.

D. Mankoff, H. Linden, J. Eary, 2012 .

Modulation of P-glycoprotein at the Human Blood-Brain Barrier by Quinidine or Rifampin Treatment: A Positron Emission Tomography Imaging Study

D. Mankoff, J. Eary, K. Domino, 2015, Drug Metabolism and Disposition.

18 F-DCFPyL-PET/CT Imaging in Patients with Biochemical Recurrence Prostate Cancer after Primary Local Therapy

J. Eary, S. Harmon, D. Citrin, 2019 .

Antibody deposition in tumor in relation to blood clearance using a nephrectomized mouse model

J. Eary, W. Nelp, K. Krohn, 1985 .